NCT00674687View on ClinicalTrials.gov

A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

June 30, 2006

Conditions

NeuralgiaNeuralgia, Postherpetic

Interventions

DRUG

2-weeks placebo then gabapentin

Placebo for 2 weeks followed by gabapentin 300 mg oral capsule once daily titrated over 1 week to gabapentin 600 mg three times daily for 1 week

DRUG

1-week placebo then gabapentin

Placebo for 1 week followed by gabapentin 300 mg oral capsule once daily titrated over 1 week to gabapentin 600 mg three times daily for 2 weeks

Trial Locations (1)

L9 7AL

Pfizer Investigational Site, Liverpool

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00674687 - A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing | Biotech Hunter | Biotech Hunter